Speaker in this video:
Dr Mukesh Kumar, Chief Scientific Officer, CLINEXEL
Topic: Efficient clinical development strategies for innovative products: Focus on emerging biotech
Key Highlights:
[1] Emerging biotech companies should adopt lean and adaptive clinical development strategies—focusing on efficient trial designs, smart use of real-world evidence, and prioritizing speed without compromising scientific rigor.
[2] Collaborations with CROs, academic institutions, and global networks can provide critical expertise, infrastructure, and regulatory support, helping smaller companies scale their clinical programs effectively.
[3] Engaging with regulators early in the development journey and aligning clinical plans with market access strategies can significantly reduce risks, optimize resources, and improve the probability of successful product launches.
The post Dr Mukesh Kumar, Chief Scientific Officer, CLINEXEL appeared first on Express Pharma.